CONCORD NEWS IN YOUR INBOX: SIGN UP HERE

Recent Quotes
My Watchlist
Indicators
New Hampshire Stocks
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Jazz Pharmaceuticals plc - Ordinary Shares (NQ:JAZZ)

165.13 +1.98 (+1.21%)
Streaming Delayed Price Updated: 10:41 AM EST, Feb 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Jazz Pharmaceuticals plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
News headline image
The Only FDA-Approved CBD Treatment For Severe Epilepsy Completes Key Phase 3 Trial In Japan Despite Missed Primary Goal ↗
 
Via Benzinga
News headline image
A Closer Look at 12 Analyst Recommendations For Jazz Pharmaceuticals ↗
 
Via Benzinga
News headline image
In a market where value is scarce, NASDAQ:JAZZ offers a refreshing opportunity with its solid fundamentals. ↗
Don't overlook JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ)—it's a hidden gem with strong fundamentals and an attractive price tag. 
Via Chartmill
News headline image
The 3 Best Cannabis Stocks to Buy in August 2024 ↗
Although cannabis stocks have been brutalized earlier, favorable legal winds could make the sector intriguing again. 
Via InvestorPlace
Topics Cannabis
News headline image
Decoding 11 Analyst Evaluations For Jazz Pharmaceuticals ↗
 
Via Benzinga
News headline image
3 Biotech Stocks to Buy on the Dip: July 2024 ↗
Biotech stocks are critically important to the broader market. However, it might make more sense to consider buying on the dip. 
Via InvestorPlace
News headline image
How Is The Market Feeling About Jazz Pharmaceuticals? ↗
 
Via Benzinga
News headline image
Assessing Jazz Pharmaceuticals: Insights From 7 Financial Analysts ↗
 
Via Benzinga
News headline image
Decoding 12 Analyst Evaluations For Jazz Pharmaceuticals ↗
 
Via Benzinga
News headline image
Sage Therapeutics Collapses 21% After Biogen-Tied Essential Tremor Drug Fails ↗
The companies are no longer developing their drug for essential tremor treatment. 
Via Investor's Business Daily
News headline image
If You Can Only Buy One Biotech Stock in July, It Better Be One of These 3 Names ↗
Evaluating and making money from biotech stocks is incredibly difficult. These three ideas should help your quest if buying in July. 
Via InvestorPlace
News headline image
Is Big Pharma Poised To Take Over Cannabis? 3 Companies Already Manage 8 In 10 Drug Prescriptions In The US ↗
The U.S. Federal Trade Commission (FTC) recently highlighted the significant influence of pharmacy benefit managers (PBMs) on drug prices due to market consolidation. This trend raises critical... 
Via Benzinga
Topics Cannabis
News headline image
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country ↗
Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) announced on Thursday that through its majority-owned subsidiary Santa Marta Golden Hemp the company... 
Via Benzinga
Topics Cannabis
News headline image
Demystifying Jazz Pharmaceuticals: Insights From 15 Analyst Reviews ↗
 
Via Benzinga
News headline image
3 Mid-Cap Growth Rockets Trading at Deep Discounts to Their Potential ↗
Large cap stocks are where the alpha is now, but there’s a case to be made for these undervalued mid-cap growth stocks 
Via InvestorPlace
News headline image
7 Biotech Stocks to Boost Your Portfolio to Peak Health ↗
With biotech stocks commanding a permanently relevant narrative, you can’t afford to ignore these highly endorsed ideas. 
Via InvestorPlace
News headline image
3 Cannabis Stocks That Could Make Your Grandchildren Rich ↗
These cannabis stocks offer long-term growth potential anchored by solid operational models and diversified revenue streams today. 
Via InvestorPlace
Topics Cannabis
News headline image
Why Is Jazz Pharmaceuticals Stock Trading Lower On Thursday? ↗
Jazz Pharmaceuticals announced Phase 2b trial results for suvecaltamide (JZP385) in essential tremor patients, revealing no significant improvements over placebo. 
Via Benzinga
News headline image
Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure ↗
The companies are working on treatments for essential tremor, a tricky indication. 
Via Investor's Business Daily
News headline image
3 Blue-Chip Stocks to Triple Your Wealth by 2026: June Edition ↗
These blue-chip stocks offer stability, sustainable growth and operational models less prone to wider economic fluctuations. 
Via InvestorPlace
News headline image
This Old Dominion Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday ↗
 
Via Benzinga
News headline image
7 Overlooked Stocks Offering Long-Term Stability From the Shadows ↗
These overlooked stocks offer price appreciation, income, and more while diversifying across sectors and company sizes. 
Via InvestorPlace
News headline image
3 Cannabis Stocks to Buy Now: May 2024 ↗
These cannabis stocks to buy offer the best odds at capturing long-term upside from current rescheduling initiatives. 
Via InvestorPlace
Topics Cannabis
News headline image
7 Blue-Chip Stocks to Buy Now: May 2024 ↗
These blue-chip stocks to buy offer long-term price appreciation opportunities reinforced with undeniable stock stability. 
Via InvestorPlace
News headline image
Cannabis Meets Prescription Drugs, Steroids And Ketamine In Schedule III: What It Means, Key Stocks To Watch ↗
President Joe Biden's administration is moving to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act (CSA). 
Via Benzinga
Topics Cannabis
News headline image
3 Cheap Blue-Chip Stocks to Buy Now: May 2024 ↗
If stock market speculation isn't quite working in your favor, these cheap blue-chip stocks may be the boost your portfolio needs. 
Via InvestorPlace
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In ↗
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028. 
Via Benzinga
Topics Cannabis
News headline image
7 Cannabis Stocks to Buy for a Smoking-Hot 2024 ↗
Ignite your portfolio with these seven sizzling cannabis stocks. From industry leaders to innovative upstarts. 
Via InvestorPlace
Topics Cannabis
News headline image
The 7 Top-Selling Cannabis Companies Ranked by Revenue: Which Weed Stocks to Buy? ↗
These top cannabis stocks by revenue are among the world's best sellers, making them prime investment opportunities to capture legal changes. 
Via InvestorPlace
Topics Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Gift this article